NP002 is a small molecule, orally available nicotinic receptor agonist that has been shown in preclinical studies to reduce LIDs without affecting parkinsonian symptoms. Neuraltus Pharma said the
Lanxess said the plant, with an annual capacity of 35,000 metric tons and around 200 employees, will manufacture products for industrial water treatment for the semi-conductor and pharmaceutical
Istodax is a member of a new class of cancer drugs known as histone deacetylase (HDAC) inhibitors. HDACs catalyse the removal of acetyl groups from acetylated lysine residues
Since 2006, Read has led Pfizer‘s Worldwide Biopharmaceutical Businesses which now comprises five global business units – Primary Care, Specialty Care, Oncology, Established Products and Emerging Markets –
Cerner clients now have access to a suite of solutions and certified integration for dose tracking from compounding to delivery. The Cerner partnership will allow health systems to
Clobazam is a 1,5-benzodiazepine that potentiates the inhibitory action of gamma-aminobutyric acid (GABA) by binding to GABA-A receptors 5,6. The prospective, double-blind, placebo controlled study enrolled 238 patients
The approved Oxycodone product line includes a 5mg capsule and 100mg/5ml oral solution. In addition to that Glenmark Generics and LVT have also signed a new supply and
Shire said that the lawsuit results from abbreviated new drug applications (ANDAs) filed by Impax and Watson for generic versions of 4mg guanfacine hydrochloride extended release tablets, INTUNIV,
MOR208 (XmAb5574) is a potent monoclonal anti-CD19 antibody to which MorphoSys recently gained worldwide access via an exclusive license and collaboration agreement with Xencor. MorphoSys and Xencor said
The open label, multi-centre, randomised Phase 2 study will evaluate the efficacy and safety of treatment with imetelstat plus paclitaxel (with or without bevacizumab) versus paclitaxel (with or
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.